DUBLIN--(BUSINESS WIRE)--Sep 3, 2018--The "Global Inhalation Anesthetics Market - Segmented by Type and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global inhalation anesthetics market is expected to register a CAGR of 4% during the forecast period of 2018-2023.

The United States inhalation anesthesia market accounted for the largest regional share in 2017. Increasing number of plastic surgeries along with rising prevalence of the chronic lower respiratory disease will fuel adoption of inhalation anesthesia.

Market Dynamics


Increasing Geriatric Population Prone to Chronic Diseases Increasing Number of Emergency Cases Growing Demand for Lesser Duration in Hospitalization Increasing Accessibility to Health Services and Surgeries


Generic Competition for Almost all of the Halogenated Agents Recent Patent Expiries Side Effects of Inhaler Anesthesia Drugs

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

Baxter AbbVie Inc. Piramal Healthcare Lunan Pharmaceuticals Co. Ltd.

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/46zpvs/global_inhalation?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180903005259/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Anesthetic Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/03/2018 12:31 PM/DISC: 09/03/2018 12:31 PM